Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H38FN3O6 |
Molecular Weight | 531.6162 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@H]1OC(=O)[C@H]2CCCN2C(=O)C3=COC(C[C@H](F)C[C@H](O)\C=C(C)\C=C\CNC(=O)\C=C\[C@H]1C)=N3
InChI
InChIKey=DFSJQGCLWZVMOD-IQIMCDJDSA-N
InChI=1S/C28H38FN3O6/c1-17(2)26-19(4)9-10-24(34)30-11-5-7-18(3)13-21(33)14-20(29)15-25-31-22(16-37-25)27(35)32-12-6-8-23(32)28(36)38-26/h5,7,9-10,13,16-17,19-21,23,26,33H,6,8,11-12,14-15H2,1-4H3,(H,30,34)/b7-5+,10-9+,18-13+/t19-,20-,21-,23-,26-/m1/s1
Molecular Formula | C28H38FN3O6 |
Molecular Weight | 531.6162 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
FLOPRISTIN is one of the components of the experimental drug NXL103 (XRP 2868), along with linopristin. Both are semi-synthetic streptogramin antibiotics derived from the Streptomyces genus. NXL103 has a spectrum of antibacterial activity that indicates it has the potential to be effective in the treatment of skin and skin structure infections, including those caused by methicillin-resistant Staphylococcus aureus, as well as community-acquired pneumonia. NXL103 has completed Phase II trials.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins. | 2006 Jan |
|
NXL-103, a combination of flopristin and linopristin, for the potential treatment of bacterial infections including community-acquired pneumonia and MRSA. | 2010 Feb |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:07:11 GMT 2023
by
admin
on
Sat Dec 16 17:07:11 GMT 2023
|
Record UNII |
OZV2QPB39M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
OZV2QPB39M
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
C81446
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
9914993
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
FLOPRISTIN
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
300000034181
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
8974
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
318498-76-9
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY | |||
|
DTXSID40953763
Created by
admin on Sat Dec 16 17:07:11 GMT 2023 , Edited by admin on Sat Dec 16 17:07:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|